E2F1 induces cell death, calpain activation, and MDMX degradation in a transcription independent manner implicating a novel role for E2F1 in neuronal loss in SIV encephalitis

Journal of Cellular Biochemistry

Volumn 96, Issue 4, 2005, Pages 728-740

  Strachan, Gordon D ^a   Koike, Maya A ^a   Siman, Robert ^a   Hall, David J ^b   Jordan Sciutto, Kelly L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Apoptosis; Calpain; Cell cycle; E2F1; Encephalitis; Lysosome; Necrosis; Neurodegeneration; Protease; SIV

Indexed keywords

CALPAIN; PROTEIN MDMX; PROTEIN P53; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HEK293; ENCEPHALITIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION INITIATION;

ANIMALS; CALPAIN; CELL CYCLE; CELL DEATH; E2F1 TRANSCRIPTION FACTOR; ENCEPHALITIS; ENZYME ACTIVATION; FLOW CYTOMETRY; GENES, REPORTER; MACACA MULATTA; MODELS, BIOLOGICAL; MUTATION; NEURONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MDM2; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 27644472289     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20574     Document Type: Article

References (63)

1. Adams PD, Kaelin WG Jr. 1996. The cellular effects of E2F overexpression. Curr Top Microbiol Immunol 208:79-93.
2. Amano T, Nakanishi H, Kondo T, Tanaka T, Oka M, Yamamoto K. 1995. Age-related changes in cellular localization and enzymatic activities of cathepsins B, L and D in the rat trigeminal ganglion neuron. Mech Ageing Dev 83:133-141.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1994. Current protocols in molecular biology. In: Janssen K, editor. Hoboken: John Wiley and Sons, Inc. pp 12.11.1-12.11.8.
4. Bahr BA, Bendiske J. 2002. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481-489.
5. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, Senik A. 2003. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278:31401-31411.
6. Black AR, Azizkhan-Clifford J. 1999. Regulation of E2F: A family of transcription factors involved in proliferation control. Gene 237:281-302.
7. Brunk UT, Dalen H, Roberg K, Hellquist HB. 1997. Photooxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23:616-626.
8. Cain K, Bratton SB, Cohen GM. 2002. The Apaf-1 apoptosome: A large caspase-activating complex. Biochimie 84:203-214.
9. Coling D, Kachar B. 2003. Principles and Application of Fluorescence Microscopy. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current Protocols in Molecular Biology. Hoboken: John Wiley & Sons, Inc. pp 14.10.
10. Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS. 2003. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23:4081-4091.
11. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250.
12. Ginsberg D. 2002. E2F1 pathways to apoptosis. FEBS Lett 529:122-125.
13. Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. 2000. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem 275:11553-11560.
14. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ. 2000. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c [see comment]. J Clin Invest 106:1127-1137.
15. Hallstrom TC, Nevins JR. 2003. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc Natl Acad Sci USA 100:10848-10853.
16. Honda R, Tanaka H, Yasuda H. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420:25-27.
17. Hou ST, Cowan E, Dostanic S, Rasquinha I, Comas T, Morley P, MacManus JP. 2001. Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons. Neurosci Lett 306:153-156.
18. Hou ST, Cowan E, Walker T, Ohan N, Dove M, Rasqinha I, MacManus JP. 2001. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 78:287-297.
19. Hsieh JK, Fredersdorf S, Kouzarides T, Martin K, Lu X. 1997. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 11:1840-1852.
20. Johnson DE. 2000. Noncaspase proteases in apoptosis. Leukemia 14:1695-1703.
21. Jordan-Sciutto KL, Dragich JM, Caltagarone J, Hall DJ, Bowser R. 2000a. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity. Biochemistry 39:3206-3215.
22. Jordan-Sciutto KL, Wang G, Murphy-Corb M, Wiley CA. 2000b. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am J Pathol 157:497-507.
23. Jordan-Sciutto K, Rhodes J, Bowser R. 2001. Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech Ageing Dev 123:11-20.
24. Jordan-Sciutto KL, Malaiyandi LM, Bowser R. 2002a. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol 61:358-367.
25. Jordan-Sciutto KL, Wang G, Murphey-Corb M, Wiley CA. 2002b. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J Neurosci 22:2185-2195.
26. Kagedal K, Zhao M, Svensson I, Brunk UT. 2001. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359:335-343.
27. Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M. 2001. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA 98:12784-12789.
28. Kulich SM, Chu CT. 2001. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: Implications for Parkinson's disease. J Neurochem 77:1058-1066.
29. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
30. Li Y, Sun X, LaMont JT, Pardee AB, Li CJ. 2003. Selective killing of cancer cells by beta-lapachone: Direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci USA 100:2674-2678.
31. Liu DX, Greene LA. 2001. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32:425-438.
32. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. 1997. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150:1933-1939.
33. Melino G, Lu X, Gasco M, Crook T, Knight RA. 2003. Functional regulation of p73 and p63: Development and cancer. Trends Biochem Sci 28:663-670.
34. Michael D, Oren M. 2003. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13:49-58.
35. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H, Helin K. 2001. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3:552-558.
36. Muller H, Moroni MC, Vigo E, Petersen BO, Bartek J, Helin K. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol 17:5508-5520.
37. Nakanishi H, Amano T, Sastradipura DF, Yoshimine Y, Tsukuba T, Tanabe K, Hirotsu I, Ohono T, Yamamoto K. 1997. Increased expression of cathepsins E and D in neurons of the aged rat brain and their colocalization with lipofuscin and carboxy-terminal fragments of Alzheimer amyloid precursor protein. J Neurochem 68:739-749.
38. Nevins JR, Leone G, DeGregori J, Jakoi L. 1997. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173:233-236.
39. O'Hare MJ, Hou ST, Morris EJ, Cregan SP, Xu Q, Slack RS, Park DS. 2000. Induction and modulation of cerebellar granule neuron death by E2F-1. J Biol Chem 275:25358-25364.
40. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860.
41. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. 1999. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 4:771-781.
42. Ranganathan S, Bowser R. 2003. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162:823-835.
43. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14:3934-3944.
44. Schoonover S, Davies P, Bowser R. 1996. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease. J Neuropathol Exp Neurol 55:444-455.
45. Schotte P, Van Criekinge W, Van de Craen M, Van Loo G, Desmedt M, Grooten J, Cornelissen M, De Ridder L, Vandekerckhove J, Fiers W, Vandenabeele P, Beyaert R. 1998. Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem Biophys Res Commun 251:379-387.
46. Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ, Jochemsen AG. 1996. MDMX: A novel p53-binding protein with some functional properties of MDM2. EMBO J 15:5349-5357.
47. Stiewe T, Putzer BM. 2000. Role of the p53-homologue p73 in E2F1-induced apoptosis [see comment]. Nat Genet 26:464-469.
48. Strachan GD, Rallapalli R, Pucci B, Lafond TP, Hall DJ. 2001. A transcriptionally inactive E2F-1 targets the MDM family of proteins for proteolytic degradation. J Biol Chem 276:45677-45685.
49. Strachan GD, Jordan-Sciutto KL, Rallapalli R, Tuan RS, Hall DJ. 2003. The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein. J Cell Biochem 88:557-568.
50. Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL, Boothman DA. 2001. Calcium is a key signaling molecule in beta-lapachone-mediated cell death. J Biol Chem 276:19150-19159.
51. Tagliarino C, Pink JJ, Reinicke KE, Simmers SM, Wuerzberger-Davis SM, Boothman DA. 2003. Mucalpain activation in beta-lapachone-mediated apoptosis. [see comment]. Cancer Biol Therapy 2:141-152.
52. Takai N, Nakanishi H, Tanabe K, Nishioku T, Sugiyama T, Fujiwara M, Yamamoto K. 1998. Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J Neurosci Res 54:214-222.
53. Tsujioka Y, Takahashi M, Tsuboi Y, Yamamoto T, Yamada T. 1999. Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue. Dement Geriatr Cogn Disord 10:192-198.
54. Vancompernolle K, Van Herreweghe F, Pynaert G, Van de Craen M, De Vos K, Totty N, Sterling A, Fiers W, Vandenabeele P, Grooten J. 1998. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438:150-158.
55. Xu K, Tavernarakis N, Driscoll M. 2001. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron 31:957-971.
56. Yamada T, Yoshiyama Y, Kawaguchi N. 1997. Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues. Brain Res 749:329-334.
57. Yamashima T. 2000. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62:273-295.
58. Yamashima T, Tonchev AB, Tsukada T, Saido TC, Imajoh-Ohmi S, Momoi T, Kominami E. 2003. Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13:791-800.
59. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52:691-698.
60. Yang Y, Mufson EJ, Herrup K. 2003. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 23:2557-2563.
61. Zetterberg A, Larsson O, Wiman KG. 1995. What is the restriction point? Curr Opin Cell Biol 7:835-842.
62. Zhu JW, DeRyckere D, Li FX, Wan YY, DeGregori J. 1999. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ 10:829-838.
63. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA. 2001. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 76:435-441.